BROOKE LARSEN: Open Payments
NPI 1427483239 · ST GEORGE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$841 in 30 payments from 14 companies in 2025. Trend: 2023 $532 · 2024 $541 · 2025 $841
Food & beverage: $841
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $152 |
| LEO Pharma Inc. | 2 | $148 |
| Galderma Laboratories, L.P. | 3 | $120 |
| Janssen Biotech, Inc. | 1 | $76 |
| Novartis Pharmaceuticals Corporation | 1 | $67 |
| UCB, Inc. | 2 | $63 |
| PFIZER INC. | 3 | $55 |
| Almirall LLC | 1 | $35 |
| Regeneron Healthcare Solutions, Inc. | 2 | $34 |
| Amgen Inc. | 1 | $22 |
Products named: SKYRIZI, ADBRY, NEMLUVIO, TREMFYA, Rhapsido, Bimzelx, CIBINQO, Seysara.
Industry payments across UT — which companies pay providers there.
